Literature DB >> 15647254

Regulation of amphetamine-stimulated dopamine efflux by protein kinase C beta.

L'Aurelle A Johnson1, Bipasha Guptaroy, David Lund, Susanna Shamban, Margaret E Gnegy.   

Abstract

Evidence suggests that protein kinase C (PKC) and intracellular calcium are important for amphetamine-stimulated outward transport of dopamine in rat striatum. In this study, we examined the effect of select PKC isoforms on amphetamine-stimulated dopamine efflux, focusing on Ca(2+)-dependent forms of PKC. Efflux of endogenous dopamine was measured in superfused rat striatal slices; dopamine was measured by high performance liquid chromatography. The non-selective classical PKC inhibitor Gö6976 inhibited amphetamine-stimulated dopamine efflux, whereas rottlerin, a specific inhibitor of PKC delta, had no effect. A highly specific PKC beta inhibitor, LY379196, blocked dopamine efflux that was stimulated by either amphetamine or the PKC activator, 12-O-tetradecanoylphorbol-13-acetate. None of the PKC inhibitors significantly altered [3H]dopamine uptake. PKC beta(I) and PKC beta(II), but not PKC alpha or PKC gamma, were co-immunoprecipitated from rat striatal membranes with the dopamine transporter (DAT). Conversely, antisera to PKC beta(I) and PKC beta(II) but not PKC alpha or PKCg amma were able to co-immunoprecipitate DAT. Amphetamine-stimulated dopamine efflux was significantly enhanced in hDAT-HEK 293 cells transfected with PKC beta(II) as compared with hDAT-HEK 293 cells alone, or hDAT-HEK 293 cells transfected with PKCa lpha or PKC beta(I). These results suggest that classical PKC beta(II) is physically associated with DAT and is important in maintaining the amphetamine-stimulated outward transport of dopamine in rat striatum.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15647254     DOI: 10.1074/jbc.M413887200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  64 in total

1.  Syntaxin 1A regulates dopamine transporter activity, phosphorylation and surface expression.

Authors:  M A Cervinski; J D Foster; R A Vaughan
Journal:  Neuroscience       Date:  2010-07-17       Impact factor: 3.590

2.  PKCbeta co-localizes with the dopamine transporter in mesencephalic neurons.

Authors:  Heather A O'Malley; Yanghae Park; Lori L Isom; Margaret E Gnegy
Journal:  Neurosci Lett       Date:  2010-08-09       Impact factor: 3.046

3.  Environmental enrichment enhances synaptic plasticity by internalization of striatal dopamine transporters.

Authors:  Myung-Sun Kim; Ji Hea Yu; Chul Hoon Kim; Jae Yong Choi; Jung Hwa Seo; Min-Young Lee; Chi Hoon Yi; Tae Hyun Choi; Young Hoon Ryu; Jong Eun Lee; Bae Hwan Lee; Hyongbum Kim; Sung-Rae Cho
Journal:  J Cereb Blood Flow Metab       Date:  2015-11-02       Impact factor: 6.200

Review 4.  Protein kinase C isozymes as regulators of sensitivity to and self-administration of drugs of abuse-studies with genetically modified mice.

Authors:  Michael Foster Olive; Philip M Newton
Journal:  Behav Pharmacol       Date:  2010-09       Impact factor: 2.293

5.  Amphetamine and methamphetamine reduce striatal dopamine transporter function without concurrent dopamine transporter relocalization.

Authors:  Christopher L German; Glen R Hanson; Annette E Fleckenstein
Journal:  J Neurochem       Date:  2012-08-23       Impact factor: 5.372

6.  N-terminus regulation of VMAT2 mediates methamphetamine-stimulated efflux.

Authors:  B Torres; A E Ruoho
Journal:  Neuroscience       Date:  2013-12-07       Impact factor: 3.590

Review 7.  The dopamine transporter: An unrecognized nexus for dysfunctional peripheral immunity and signaling in Parkinson's Disease.

Authors:  Phillip Mackie; Joe Lebowitz; Leila Saadatpour; Emily Nickoloff; Peter Gaskill; Habibeh Khoshbouei
Journal:  Brain Behav Immun       Date:  2018-03-15       Impact factor: 7.217

8.  Proline-directed phosphorylation of the dopamine transporter N-terminal domain.

Authors:  Balachandra K Gorentla; Amy E Moritz; James D Foster; Roxanne A Vaughan
Journal:  Biochemistry       Date:  2009-02-10       Impact factor: 3.162

9.  Protein kinase Cβ is a modulator of the dopamine D2 autoreceptor-activated trafficking of the dopamine transporter.

Authors:  Rong Chen; Conor P Daining; Haiguo Sun; Rheaclare Fraser; Stephanie L Stokes; Michael Leitges; Margaret E Gnegy
Journal:  J Neurochem       Date:  2013-03-18       Impact factor: 5.372

10.  Nongenomic mechanisms of physiological estrogen-mediated dopamine efflux.

Authors:  Rebecca A Alyea; Cheryl S Watson
Journal:  BMC Neurosci       Date:  2009-06-16       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.